profile_id,first_name,last_name,sub_title,profile_picture,background_image,profile_type,entity_urn,object_urn,birth_date,summary,location,premium,influencer,treasury_media,languages,industry,education,patents,awards,certifications,organizations,projects,publications,courses,test_scores,position_groups,volunteer_experiences,skills,network_info,related_profiles,contact_info
sangramkale,Sangram,Kale,"Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry",https://media.licdn.com/dms/image/C4D03AQH-uyVIozlu2Q/profile-displayphoto-shrink_800_800/0/1583836982602?e=1697673600&v=beta&t=hMnOt3KuWxo5x-1vzXmUBKLi7kXWl7c9OZhM1ib0Akg,,personal,ACoAAA-WlaoBHfN7vD_ZZfkRdZhR_elywHaUu2E,261526954,,"peptide/protein discovery and development scientist. 

I’m research scientist working to develop technologies that benefit human health. My main area of interest is discovery and development of pharmaceutical drug entities. I have more than 6 years of post-Ph.D. experience in peptide therapeutics, medicinal chemistry and protein/antibody. My key strength is phage display screening, lead generation and optimization, project management and have experience working with modalities like small molecule, peptide, macrocycle, protein and antibody. I have very good knowledge and skills in peptide chemistry, medicinal chemistry, peptide and antibody phage display, high-throughput screening, pharmacokinetics, molecular biology, biological assays, bioanalytical and biophysical tools.

A little about me…

Originally from India, now reside in Amsterdam area and continue to serve global clients for peptide/protein/antibody discovery and development project. One of main role is to expand exiting peptide-phage discovery technology and managing internal and external projects. I am very much looking forward to working on challenging projects.

Prior to that as a scientific staff, I have contributed in establishing protein-peptide phage display technology on safe drugs for pain and inflammation using phage display at Max Planck Institute for Medical Research. 

During my postdoctoral tenure at EPFL, I have managed various projects and developed two-platform technology for early drug discovery based on double bridge peptide-phage display and traceless high-throughput screening of macrocycles. I have also performed antibody phage display against Tacrolimus to develop point-of-care diagnostic applications and selective bioconjugation of antibody.

I am a chemist by training, did my Ph.D. in chemistry. I have contributed in the field of on peptide, bioorganic and medicinal chemistry. I have designed, synthesized and studied novel peptide foldamers and performed multistep organic synthesis of peptidomimetics and natural products.
","{'country': 'Netherlands', 'short': 'Lelystad, Flevoland', 'city': 'Lelystad', 'state': 'Flevoland', 'default': 'Lelystad, Flevoland, Netherlands'}",False,False,"[{'url': 'https://actu.epfl.ch/news/double-bridged-peptides-bind-any-disease-target/', 'title': 'Double-bridged peptides bind any disease target', 'description': 'EPFL scientists have developed a new type of ""double-bridged peptide"" that can be tailored to bind tightly to disease targets of interest. The peptides’ highly efficient binding, combined with their small size and high stability make them ideal for...', 'image': 'https://media.licdn.com/dms/image/sync/C5627AQG20HPVhUOkoQ/articleshare-shrink_1280_800/0/1691415046681?e=1692964800&v=beta&t=tD8XzAFLGchEMcEfXCpE3edJL2P70TuIFH-ugInwTJU'}, {'url': 'https://actu.epfl.ch/news/new-cyclization-reactions-for-synthesizing-macro-2/', 'title': 'New cyclization reactions for synthesizing macrocyclic drug leads', 'description': 'Scientists at EPFL have developed a new method to synthesize and screen thousands of macrocyclic compounds, a family of chemicals that are of great interest in the pharmaceutical industry. The study is published in Science Advances.', 'image': 'https://media.licdn.com/dms/image/sync/C5627AQF5H4R2T1_7MQ/articleshare-shrink_1280_800/0/1692109963273?e=1692964800&v=beta&t=hHg2gP3zROpg9KliPx-z_QMbfyZpGrIh1MqS8X8hv-w'}]","{'primary_locale': {'country': 'US', 'language': 'en'}, 'supported_locales': [{'country': 'US', 'language': 'en'}], 'profile_languages': [{'name': 'English', 'proficiency': 'FULL_PROFESSIONAL'}, {'name': 'German', 'proficiency': 'ELEMENTARY'}, {'name': 'Hindi', 'proficiency': 'NATIVE_OR_BILINGUAL'}, {'name': 'Marathi', 'proficiency': 'NATIVE_OR_BILINGUAL'}]}",Research,"[{'date': {'start': {'month': None, 'day': None, 'year': 2007}, 'end': {'month': None, 'day': None, 'year': 2013}}, 'school': {'name': 'Savitribai Phule Pune University', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQEFsIyAZyuMwA/company-logo_400_400/0/1519904707827?e=1700697600&v=beta&t=zHW9YSD5yaXAQm8gbuxw0i-bxs8oGvkNEls77mQjJ7c', 'url': 'https://www.linkedin.com/school/university-of-pune/'}, 'degree_name': 'Doctor of Philosophy (Ph.D.)', 'field_of_study': 'Chemistry'}, {'date': {'start': {'month': None, 'day': None, 'year': 2005}, 'end': {'month': None, 'day': None, 'year': 2007}}, 'school': {'name': 'Savitribai Phule Pune University', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQEFsIyAZyuMwA/company-logo_400_400/0/1519904707827?e=1700697600&v=beta&t=zHW9YSD5yaXAQm8gbuxw0i-bxs8oGvkNEls77mQjJ7c', 'url': 'https://www.linkedin.com/school/university-of-pune/'}, 'degree_name': 'Master’s Degree', 'field_of_study': 'Organic Chemistry'}]",[],"[{'title': 'Senior Research Fellowship', 'description': None, 'issuer': 'Council for Scientific and Industrial Research (CSIR) ', 'date': {'month': 6, 'day': None, 'year': 2009}}, {'title': 'Junior Research Fellowship', 'description': None, 'issuer': 'Council for Scientific and Industrial Research (CSIR) ', 'date': {'month': 6, 'day': None, 'year': 2006}}]",[],[],[],"[{'name': 'Thiol-assisted small molecule macrocycle libraries and screening', 'publisher': 'Science Advances', 'url': 'https://advances.sciencemag.org/content/5/8/eaaw2851?rss=1', 'date': {'month': None, 'day': None, 'year': 2019}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Cyclization of peptides with two chemical bridges affords large scaffold diversities', 'publisher': 'Nature Chemistry', 'url': 'https://www.nature.com/articles/s41557-018-0042-7', 'date': {'month': None, 'day': None, 'year': 2018}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Polar Hinges as Functionalized Conformational Constraints in (Bi)cyclic Peptides', 'publisher': 'ChemBioChem', 'url': 'https://onlinelibrary.wiley.com/doi/full/10.1002/cbic.201600612', 'date': {'month': None, 'day': None, 'year': 2016}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Self-assembled vesicles of urea-tethered foldamers as hydrophobic drug carriers', 'publisher': 'Chemical Communications', 'url': 'https://pubs.rsc.org/en/content/articlelanding/2016/cc/c6cc05079d#!divAbstract', 'date': {'month': None, 'day': None, 'year': 2016}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Novel hybrid nocodazole analogs as tubulin polymerization inhibitors and their antiproliferative activity', 'publisher': 'Bioorganic & Medicinal Chemistry Letter', 'url': 'https://www.sciencedirect.com/science/article/pii/S0960894X15002152', 'date': {'month': None, 'day': None, 'year': 2015}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Conformational modulation of peptide secondary structures using β-amino benzenesulfonic acid', 'publisher': 'Chemical Communications', 'url': 'https://pubs.rsc.org/en/content/articlelanding/2014/CC/c3cc48850k#!divAbstract', 'date': {'month': None, 'day': None, 'year': 2014}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'The Ant-Pro Reverse-Turn Motif: Structural Features and Conformational Characteristics.', 'publisher': 'European Journal of Organic Chemistry', 'url': 'https://onlinelibrary.wiley.com/doi/10.1002/ejoc.201201739', 'date': {'month': None, 'day': None, 'year': 2013}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Carboxamide vs Sulfonamide in Peptide Backbone Folding: A Case Study with a Synthetic Oligomer', 'publisher': 'Organic Letters', 'url': 'https://pubs.acs.org/doi/abs/10.1021/ol4002762', 'date': {'month': None, 'day': None, 'year': 2013}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Orthanilic acid-Promoted Reverse-Turn Formation in Peptides', 'publisher': 'Chemical Communications', 'url': 'https://pubs.rsc.org/en/content/articlelanding/2013/CC/c3cc40522b#!divAbstract', 'date': {'month': None, 'day': None, 'year': 2013}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Conformational Modulation of Ant-Pro Oligomers using Chirality Alteration of Proline Residues', 'publisher': 'Organic & Biomolecular Chemistry', 'url': 'https://pubs.rsc.org/en/content/articlelanding/2012/OB/c2ob26132d#!divAbstract', 'date': {'month': None, 'day': None, 'year': 2012}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Bicyclic Amino Acid-Carbohydrate-Conjugates as Conformationally Restricted Hydroxyethylamine (HEA) Transition-State Isosteres', 'publisher': 'Organic & Biomolecular Chemistry', 'url': 'https://pubs.rsc.org/en/content/articlelanding/2011/OB/c1ob06215h#!divAbstract', 'date': {'month': None, 'day': None, 'year': 2011}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}, {'name': 'Sequence-Specific Unusual (1→2)-type Helical Turns in α/β-Hybrid Peptides', 'publisher': 'Journal of American Chemical Society', 'url': 'https://pubs.acs.org/doi/10.1021/ja804297f', 'date': {'month': None, 'day': None, 'year': 2008}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Sangram', 'last_name': 'Kale', 'name': None, 'headline': 'Lead Scientist, Peptide Discovery at Biosynth (Pepscan) | Peptide Chemistry | Phage display | Medicinal Chemistry'}]}]","[{'name': 'Bioorganic and Medicinal Chemsitry', 'number': None}, {'name': 'NMR', 'number': None}, {'name': 'Organic Chemistry', 'number': None}]",[],"[{'company': {'id': 9444277, 'name': 'Biosynth', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQEldGuTYLuEdA/company-logo_400_400/0/1662549819538?e=1700697600&v=beta&t=JTcAQqlh57UENrNrhifOpU9KjKecqgNU4MiptvJzMN8', 'url': 'https://www.linkedin.com/company/biosynth/', 'employees': {'start': 501, 'end': 1000}}, 'date': {'start': {'month': 2, 'day': None, 'year': 2020}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'Lelystad, Flevoland, Netherlands', 'date': {'start': {'month': 6, 'day': None, 'year': 2022}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'Biosynth', 'description': None, 'title': 'Lead Scientist', 'employment_type': 'Full-time'}, {'location': 'Lelystad, Flevoland, Netherlands', 'date': {'start': {'month': 2, 'day': None, 'year': 2020}, 'end': {'month': 6, 'day': None, 'year': 2022}}, 'company': 'Biosynth', 'description': '•\tLeading peptide discovery and development projects for pharma and academic clients.\n•\tExpanding peptide discovery platform.\n•\tContributing in in-house discovery projects.\n•\tSteering and leading lab chemist and biologist in drug discovery and development projects.', 'title': 'Scientist', 'employment_type': 'Full-time'}]}, {'company': {'id': 11304648, 'name': 'Max Planck Institute for Medical Research', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQEI2-s4UyuTsQ/company-logo_400_400/0/1678267733445?e=1700697600&v=beta&t=-WbXrEskUeb8_75J30P7k3hNEJtsl9KRd0A873XZytA', 'url': 'https://www.linkedin.com/company/mpimr/', 'employees': {'start': 201, 'end': 500}}, 'date': {'start': {'month': 8, 'day': None, 'year': 2019}, 'end': {'month': 1, 'day': None, 'year': 2020}}, 'profile_positions': [{'location': 'Heidelberg Area, Germany', 'date': {'start': {'month': 8, 'day': None, 'year': 2019}, 'end': {'month': 1, 'day': None, 'year': 2020}}, 'company': 'Max Planck Institute for Medical Research', 'description': 'Worked with Prof. Dr. Kai Johnsson at Chemical Biology group\n\n•\tPlayed key-role in establishing self-labeling protein-peptide phage display for the development of safe drugs for pain and inflammation.  \n•\tGained experience and skills in molecular biology, primer design, cloning, qPCR, protein expression, capillary western blot, and biosensors', 'title': 'Scientific Staff', 'employment_type': None}]}, {'company': {'id': 3883, 'name': 'EPFL (École polytechnique fédérale de Lausanne)', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQH2roCFqd0gPA/company-logo_400_400/0/1552924931981?e=1700697600&v=beta&t=Z_jK9-_Ht9P_TlcliWj9KQv_XjCmxgzGkjxJraZepoQ', 'url': 'https://www.linkedin.com/school/epfl/', 'employees': {'start': 1001, 'end': 5000}}, 'date': {'start': {'month': 1, 'day': None, 'year': 2014}, 'end': {'month': 7, 'day': None, 'year': 2019}}, 'profile_positions': [{'location': 'Lausanne Area, Switzerland', 'date': {'start': {'month': 1, 'day': None, 'year': 2014}, 'end': {'month': 7, 'day': None, 'year': 2019}}, 'company': 'EPFL (École polytechnique fédérale de Lausanne)', 'description': 'Worked with Prof. Christian Heinis at Laboratory of Peptide and Protein Therapeutics\n\n•\tLead and developed two platform technologies for early drug discovery\n       -\tdouble bridge peptide-phage display \n       -\ttraceless high-throughput screening\n•\tDeveloped high-affinity ligands against human plasma Kallikrien, Interleukin 17 (IL17) and other therapeutic targets using peptide phage display.\n•\tPerformed antibody phage display and identified antibody against Tacrolimus for diagnostic purpose.\n•\tGained expertise and skills in peptide therapeutics, project management and communication. Published high impact factor publications included one in Nature Chemistry and Science Advances.\n•\tPeptide and antibody phage display, peptide chemistry, bioanalytical and biophysical assay, ELISA, SPR, WB, HPLC, LCMS, protein/antibody expression', 'title': 'Postdoctoral Researcher', 'employment_type': None}]}, {'company': {'id': 348289, 'name': 'National Chemical Laboratory', 'logo': 'https://media.licdn.com/dms/image/C560BAQHdiI1z1EgLQA/company-logo_400_400/0/1519890913089?e=1700697600&v=beta&t=Qx6c6SMtCmcaSn2X5xL6JKagprUOWazwCrCZ3ybZLPM', 'url': 'https://www.linkedin.com/company/national-chemical-laboratory/', 'employees': {'start': 1001, 'end': 5000}}, 'date': {'start': {'month': 7, 'day': None, 'year': 2007}, 'end': {'month': 8, 'day': None, 'year': 2013}}, 'profile_positions': [{'location': 'Pune Area, India', 'date': {'start': {'month': 7, 'day': None, 'year': 2007}, 'end': {'month': 8, 'day': None, 'year': 2013}}, 'company': 'National Chemical Laboratory', 'description': '•\tDesign, synthesis and structural characterization of novel peptide foldamers.\n•\tPerformed small molecule medicinal chemistry, peptide chemistry and multistep synthesis of peptidomimetics.\n•\tCompleted course work in orgnaic syntheis, NMR and bioorganic and medicinal Chemistry\n•\tGained experience in synthetic organic and peptide chemistry, medicinal and bioorganic chemistry, analytics, published 9 research articles in reputed journals.', 'title': 'Ph.D. Chemistry', 'employment_type': None}]}]",[],"['Drug Discovery', 'Peptide Chemistry', 'Phage Display', 'Organic Synthesis', 'Chemistry', 'Organic Chemistry', 'NMR', 'HPLC', 'Chromatography', 'Research', 'Spectroscopy', 'Nuclear Magnetic Resonance (NMR)', 'High-Performance Liquid Chromatography (HPLC)', 'Mass Spectrometry', 'LC-MS', 'UV/Vis Spectroscopy', 'Purification', 'Biochemistry', 'Analytical Chemistry', 'Screening']",,,
